admin Share This! FacebookTwitterPinterestLinkedIn Investing News Pfizer Shares Drop as It Ends Study of Weight-Loss Pill Due to Patient Side Effects 11 months ago80 Views1 Min Read Pfizer shares lost ground after ending a study of a twice-a-day weight-loss pill because of negative side effects. You may also like Investing News What a $295 Million House Really Costs 2 hours ago Investing News Should You Pay in Cash? 2 hours ago Investing News Understanding the Gann Studies 5 hours ago Midday Movers: Ulta Beauty and Paramount Global Rise, Pfizer and Tesla Fall Top Technolgy Stocks for Q4 2023 Share This! FacebookTwitterPinterestLinkedIn Newsletter NavigationInvesting News Market Insider Stock Market Stocks to buy Stocks to sell Dividend Stocks Trader Talk Videos Privacy Policy DMCA / Copyrights Disclaimer Terms and Conditions Disclaimer Whitelist Us